3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Leukemia, Myeloid, Acute
45
Breast Neoplasms
20
Myelodysplastic Syndromes
19
Prostatic Neoplasms
12
Neoplasms
12
Leukemia, Myelomonocytic, Chronic
12
Carcinoma, Hepatocellular
10
Stomach Neoplasms
9
Recurrence
9
Carcinoma, Non-Small-Cell Lung
8
Neoplasm Metastasis
7
Esophageal Neoplasms
7
Uterine Cervical Neoplasms
6
Sarcoma
6
Ovarian Neoplasms
6
Multiple Myeloma
6
Lung Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myeloproliferative Disorders
5
Melanoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma, B-Cell
5
Esophageal Squamous Cell Carcinoma
5
Colorectal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Myelodysplastic-Myeloproliferative Diseases
4
Leukemia, Biphenotypic, Acute
4
Cholangiocarcinoma
4
Thrombocythemia, Essential
3
Interventions
lanreotide
1
Temozolomide
1
Surveys and Questionnaires
1
Solutions
1
Radiosurgery
1
Microarray Analysis
1
Injections
1
Early Intervention, Educational
1
Diet, Mediterranean
1
Diet, Ketogenic
1
DNA Methylation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Growth Hormone-Secreting Pituitary Adenoma
×
Injections
×
Clear all
NCT03439709
2018-03-01
MERGE
Samsung Medical Center
Phase 3
Unknown
90 enrolled